Arvinas NASDAQ IPO

30/8/2018
IPO

Announced

30/8/2018


Overview:

  • Arvinas aims to raise $100 million with its IPO on NASDAQ.

Mihail Georgiev - Data analyst

Jurisdictions:

United States
New York

Deal type:

IPO

Practice area:

Capital markets : Equity

Governing laws:

New York
United States

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Goldman Sachs (Underwriter)

Party: Citigroup (Underwriter)

Party: Piper Jaffray & Co (Underwriter)


Party: Arvinas (Issuer)